These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22899435)

  • 1. A semi-quantitative serological method to assess the potency of inactivated rabies vaccine for veterinary use.
    Liu Y; Zhang S; Zhang F; Hu R
    Virol Sin; 2012 Aug; 27(4):259-64. PubMed ID: 22899435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
    Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
    Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency testing of inactivated rabies vaccines using a serological method.
    Kamphuis E; Krämer B; Schildger H; Duchow K
    Dev Biol (Basel); 2012; 134():23-7. PubMed ID: 22888591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of G2 Citric Acid-Based Dendrimer as an Adjuvant in Veterinary Rabies Vaccine.
    Asgary V; Shoari A; Afshar Moayad M; Shafiee Ardestani M; Bigdeli R; Ghazizadeh L; Khosravy MS; Panahnejad E; Janani A; Bashar R; Abedi M; Ahangari Cohan R
    Viral Immunol; 2018; 31(1):47-54. PubMed ID: 29328884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine.
    Sigoillot-Claude C; Battaglio M; Fiorucci M; Gillet D; Vimort AS; Giraud Y; Laurent S; Vaganay A; Poulet H
    Vaccine; 2015 Jul; 33(32):3843-9. PubMed ID: 26144898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibody response in dogs and cats inoculated with commercial inactivated rabies vaccines.
    Shiraishi R; Nishimura M; Nakashima R; Enta C; Hirayama N
    J Vet Med Sci; 2014 Apr; 76(4):605-9. PubMed ID: 24389741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and pre-validation of a quantitative multi-dose serological assay for potency testing of inactivated rabies vaccines for human use.
    Moreira WC; Freitas JFS; Machado NS; Almeida AECC; Moura WC
    J Virol Methods; 2019 Jan; 263():54-59. PubMed ID: 30393149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a non-invasive, inhalational challenge method for rabies vaccine potency assay.
    Lewis CE; Reising MM; Fry AM; Conrad SK; Siev D; Gatewood DM; Hermann JR
    J Virol Methods; 2013 Jun; 190(1-2):49-52. PubMed ID: 23557669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.
    Krämer B; Schildger H; Behrensdorf-Nicol HA; Hanschmann KM; Duchow K
    Biologicals; 2009 Apr; 37(2):119-26. PubMed ID: 19181541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermotolerance of an inactivated rabies vaccine for dogs.
    Lankester FJ; Wouters PAWM; Czupryna A; Palmer GH; Mzimbiri I; Cleaveland S; Francis MJ; Sutton DJ; Sonnemans DGP
    Vaccine; 2016 Nov; 34(46):5504-5511. PubMed ID: 27729174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine.
    Nunberg JH; Doyle MV; York SM; York CJ
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4240-3. PubMed ID: 2786210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possibility of Immediate Introduction of a Single-Dose Antibody Induction Test as a Refinement of the NIH Test for Inactivated Rabies Vaccine Potency Determination.
    Stankov S; Obradović N; Vujin D; Vranješ N
    Viral Immunol; 2020 Jun; 33(5):367-377. PubMed ID: 32159457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera.
    Thraenhart O; Ramakrishnan K
    J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant activity of PCP-II, a polysaccharide from Poria cocos, on a whole killed rabies vaccine.
    Zhang W; Cheng N; Wang Y; Zheng X; Zhao Y; Wang H; Wang C; Han Q; Gao Y; Shan J; Yang S; Xia X
    Virus Res; 2019 Sep; 270():197638. PubMed ID: 31173772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-protein based ELISA as a potency test for rabies vaccines.
    Chabaud-Riou M; Moreno N; Guinchard F; Nicolai MC; Niogret-Siohan E; Sève N; Manin C; Guinet-Morlot F; Riou P
    Biologicals; 2017 Mar; 46():124-129. PubMed ID: 28214171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
    Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
    J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan.
    Gamoh K; Shimazaki Y; Senda M; Makie H; Itoh O; Muramatsu M; Hirayama N; Hatakeyama H
    J Vet Med Sci; 2003 Jun; 65(6):685-8. PubMed ID: 12867727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Testing for immunogenic and protective properties of vaccine against tissue-inactivated rabies].
    Vrzal V; Cupera Z; Chumela J; Zatloukal L
    Vet Med (Praha); 1990 Feb; 35(2):87-95. PubMed ID: 2353410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective vaccination against rabies in puppies in rabies endemic regions.
    Morters MK; McNabb S; Horton DL; Fooks AR; Schoeman JP; Whay HR; Wood JL; Cleaveland S
    Vet Rec; 2015 Aug; 177(6):150. PubMed ID: 26109286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Time and Cost Benefit Antibody Binding Test-Based Method for Determination of Rabies Vaccine Potency.
    Asgary V; Mojtabavi N; Janani A; Mousavi T; Hadjati J; Khosravy MS; Ahangari Cohan R
    Viral Immunol; 2017 Apr; 30(3):204-209. PubMed ID: 28118120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.